← Leaderboards
Kristine Mace Erlandson
University Of Colorado Denver
$8,182,581
Attributed
$12,096,335
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2011–25$2.5M$1.9M$1.3M$625K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,096,335 · 8
By mechanism
R01$10,074,118 · 4
K23$946,053 · 1
K24$576,219 · 1
R21$346,945 · 1
R03$153,000 · 1
Top collaborators
- Allison R Webel6 shared
- Lindsay Tara Fourman2 shared
- Kelly O'Brien2 shared
- Jordan E Lake1 shared
- Jennifer E. Stevens-Lapsley1 shared
- Markella V. Zanni1 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Dawon Baik$765,254
- Cara C Wilson$18,310,415
- Robert A Meguid$1,288,721
Others in their field
Top investigators on “Aging”
- Lawrence Corey · Fred Hutchinson Cancer Center$506,603,345
- David R. Weir · University Of Michigan At Ann Arbor$421,002,438
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$351,438,389
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$281,021,854
- George R Seage · Abt Associates, Inc.$218,167,298
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$210,610,900
Research focus
AgingPersonsPhysical FunctionElderlyRandomizedImpairmentParticipantClinical TrialsCaringAdultMorbidity - Disease RateDesignMortalityAgedMuscleUnited States National Institutes Of HealthGeriatricsColoradoPreventMuscle FormExerciseFrailtyDisabilityAntiretroviral Therapy
Grant awards (28)
Incretin Microdosing for Cardiometabolic Health in People With HIV: The REINFORCE Trial$966,521
R01 · FY2025 · DK
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV (TRIUMPH)$665,909
R01 · FY2025 · AG
Mentoring Across Disciplines: Aging and Infectious Diseases with a Focus on Mobility$192,144
K24 · FY2025 · AG · contact PI
The High-Intensity Exercise to Attenuate Limitations and Train Habits (HEALTH) in Older Adults with HIV$777,338
R01 · FY2024 · AG · contact PI
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV (TRIUMPH)$697,594
R01 · FY2024 · AG
Mentoring Across Disciplines: Aging and Infectious Diseases with a Focus on Mobility$192,144
K24 · FY2024 · AG · contact PI
The High-Intensity Exercise to Attenuate Limitations and Train Habits (HEALTH) in Older Adults with HIV$783,778
R01 · FY2023 · AG · contact PI
Mitochondria and Muscle within the HEALTH Study$403,074
R01 · FY2023 · AG · contact PI
Mentoring Across Disciplines: Aging and Infectious Diseases with a Focus on Mobility$191,931
K24 · FY2023 · AG · contact PI
The High-Intensity Exercise to Attenuate Limitations and Train Habits (HEALTH) in Older Adults with HIV$766,260
R01 · FY2022 · AG · contact PI
The High-Intensity Exercise to Attenuate Limitations and Train Habits (HEALTH) in Older Adults with HIV$774,572
R01 · FY2021 · AG · contact PI
The High-Intensity Exercise to Attenuate Limitations and Train Habits (HEALTH) in Older Adults with HIV$799,851
R01 · FY2020 · AG · contact PI
Pitavastatin to REduce Physical Function Impairment and FRailty in HIV (PREPARE)$540,103
R01 · FY2020 · AG · contact PI
Predictors of Recovery and the App-Facilitated Tele-Rehabilitation (AFTER) Program for COVID Survivors$523,492
R01 · FY2020 · AG · contact PI
Advancing Assessment of Episodic Disability to Enhance Healthy Aging among Adults with HIV: Developing a Short-Form HIV Disability Questionnaire (HDQ) for use in Clinical Practice$171,621
R21 · FY2020 · AG
Pitavastatin to REduce Physical Function Impairment and FRailty in HIV (PREPARE)$565,920
R01 · FY2019 · AG · contact PI
Advancing Assessment of Episodic Disability to Enhance Healthy Aging among Adults with HIV: Developing a Short-Form HIV Disability Questionnaire (HDQ) for use in Clinical Practice$175,324
R21 · FY2019 · AG
Pitavastatin to REduce Physical Function Impairment and FRailty in HIV (PREPARE)$585,622
R01 · FY2018 · AG · contact PI
The Impact of HIV and Aging on Physical Function and the Somatopause.$179,388
K23 · FY2018 · AG · contact PI
Pitavastatin to REduce Physical Function Impairment and FRailty in HIV (PREPARE)$599,344
R01 · FY2017 · AG · contact PI
The Impact of HIV and Aging on Physical Function and the Somatopause.$179,388
K23 · FY2017 · AG · contact PI
Pitavastatin to REduce Physical Function Impairment and FRailty in HIV (PREPARE)$624,740
R01 · FY2016 · AG · contact PI
The Impact of HIV and Aging on Physical Function and the Somatopause.$179,388
K23 · FY2016 · AG · contact PI
The Impact of HIV and Aging on Physical Function and the Somatopause.$179,388
K23 · FY2015 · AG · contact PI
Barriers and Facilitators to Exercise Maintenance$49,113
K23 · FY2015 · AG · contact PI
The Impact of HIV and Aging on Physical Function and the Somatopause.$179,388
K23 · FY2014 · AG · contact PI
Mechanisms of Frailty in HIV-1 Infection$76,500
R03 · FY2012 · AG · contact PI
Mechanisms of Frailty in HIV-1 Infection$76,500
R03 · FY2011 · AG · contact PI